Carregant...

Advances in preclinical approaches to Chagas disease drug discovery

INTRODUCTION: Chagas disease affects 8–10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Expert Opin Drug Discov
Autors principals: Villalta, Fernando, Rachakonda, Girish
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779130/
https://ncbi.nlm.nih.gov/pubmed/31411084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1652593
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!